Medical Ethics
RSSArticles
-
Does Use of Biospecimens From Children Require Reconsent When They Are Adults?
There is considerable ethical debate about the issue of reconsent at age 18 from research subjects who provided biospecimens as infants, children, or adolescents. Practices currently vary widely among institutions.
-
Shared Decision-making Is ‘Moral Imperative’ Despite Challenges in ED
Shared decision-making is an important concept for patient autonomy, but how does it play out in the unique ED setting?
-
Study: Less Money Spent on End-of-Life Care for Rural Medicare Patients
Medicare expenditures are lower for rural beneficiaries with cancer than urban beneficiaries, found a recent study.
-
Nurses Report Barriers to Involving Family Caregivers
Patient care demands, the professional practice environment, and lack of resources hindered nursing family caregiver involvement, found a recent survey of 374 critical care nurses.
-
Education Needs Still Unmet for Family Presence During Resuscitation
Critical care nurses’ needs for education on family presence during resuscitation are not being met, found a recent survey of 395 critical care nurses.
-
Novel Training Program Pairs Clinicians With Chaplains
Patients’ spiritual needs often go unaddressed due to providers’ lack of prioritization, time, and training. A novel training program pairs clinicians and chaplains.
-
Proposed Model Ethics Curriculum Developed for Dermatology Residency
Standardized methods to teach ethics skills in dermatology residencies are currently unavailable. A recent paper offers a model curriculum.
-
Ethics Services Report Unprecedented Surge in Demand for Consultations
At the same time ethics consultation services are seeing a surge in demand, cases are increasing in complexity.
-
Soul-searching: Spiritual Counseling for Healthcare Workers
Religious and spiritual leaders in hospitals can give healthcare workers a safe space to ask unanswerable questions and process frayed emotions.
-
Right to Try Law Raises Questions About FDA, IRB Oversight
The FDA “remains committed” to reviewing and approving investigational drugs through its expanded access program, which will continue in conjunction with the recently enacted federal Right to Try law.